CITIGROUP INC

Position in ADCT — ADC Therapeutics SA

CIK 831001 NEW YORK, NY

Position in ADCT

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$53,148

-$65,614 QoQ

Shares Held

49,672

+56.8% QoQ

Ownership

0.039%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#53

of 113 holders

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $573,447,136 across 59 Drug Manufacturers - Specialty & Generic names. ADCT ranks #45 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	262,200	$142,067,824
2	ZTS	Zoetis Inc.	1,265,210	$90,917,989
3	TEVA	Teva Pharmaceutical Industries Ltd	2,527,031	$85,615,809
4	VTRS	Viatris Inc	4,360,444	$69,243,850
5	NBIX	Neurocrine Biosciences Inc	179,076	$30,181,467
6	INDV	Indivior Pharmaceuticals, Inc.	643,006	$26,382,535
7	LNTH	Lantheus Holdings, Inc.	189,692	$21,044,429
8	HLN	Haleon plc	1,507,538	$14,065,329

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$53,148	49,672	+56.8%	Shares	Defined	2026-08-03
2026-03-31	$118,762	31,670	+96.6%	Shares	Defined	2026-05-11
2025-12-31	$56,864	16,109	+367.7%	Shares	Defined	2026-02-13
2025-09-30	$13,776	3,444	-86.8%	Shares	Defined	2025-11-10
2025-06-30	$69,920	26,090	-54.7%	Shares	Defined	2025-08-11
2025-03-31	$81,280	57,646	-10.1%	Shares	Defined	2025-05-12
2024-12-31	$127,636	64,139	+8.9%	Shares	Defined	2025-02-12
2024-09-30	$185,541	58,902	+281.9%	Shares	Defined	2024-11-12
2024-06-30	$48,736	15,423	+740.9%	Shares	Defined	2024-08-12
2023-06-30	$3,943	1,834	+4726.3%	Shares	Defined	2023-08-10
2022-12-31	$145	38	+22.6%	Shares	Defined	2023-02-09
2022-09-30	$149	31	-6.1%	Shares	Defined	2022-11-10
2022-06-30	$262	33	0.0%	Shares	Defined	2022-08-10
2022-03-31	$484	33	+3.1%	Shares	Defined	2022-05-12
2021-12-31	$646	32	—	Shares	Defined	2022-02-10
No filing history on record for this holder in this stock.